Cosmo N.V. (FRA:C43)

Germany flag Germany · Delayed Price · Currency is EUR
100.00
-1.00 (-0.99%)
Last updated: Apr 24, 2026, 9:56 AM CET
Market Cap1.67B +83.4%
Revenue (ttm)104.17M -61.0%
Net Income-3.61M
EPS-0.23
Shares Outn/a
PE Ration/a
Forward PE1,366.10
Dividend2.10 (2.00%)
Ex-Dividend DateApr 24, 2026
Volumen/a
Average Volume111
Open98.80
Previous Close101.00
Day's Range98.80 - 100.00
52-Week Range47.80 - 141.00
Betan/a
RSI51.02
Earnings DateJul 20, 2026

About Cosmo

Cosmo N.V., a life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral ... [Read more]

Industry Pharmaceutical Preparations
Founded 1997
Employees 325
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol C43

Financial Performance

Financial Statements